Evidence map›Paper›PMID 21435458›Full record

ArticleThe American journal of pathology2011

Circulating endothelial progenitor cells are up-regulated in a mouse model of endometriosis.

Christian M Becker, Paul Beaudry, Tae Funakoshi, Ofra Benny, Alexander Zaslavsky, David Zurakowski, Judah Folkman, Robert J D'Amato, Sandra Ryeom

Open access · hybridAbstract read
In one paragraph

Article in The American journal of pathology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
10.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 81 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Pathogenesis of Endometriosis and Endometriosis-Associated Cancers.International journal of molecular sciences · 2024
    Review
  5. Article
  6. Dienogest in endometriosis treatment: A narrative literature review.Clinical and experimental reproductive medicine · 2023
    Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. The Origin and Pathogenesis of Endometriosis.Annual review of pathology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Application of Dendrimer-based Nanoparticles in Glioma Imaging.Journal of nanomedicine & nanotechnology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Christian M BeckerVascular Biology Program, Children's Hospital Boston, Harvard Medical School, Boston, Massachusetts, USA. christian.becker@obs-gyn.ox.ac.uk
Paul Beaudry
Tae Funakoshi
Ofra Benny
Alexander Zaslavsky
David Zurakowski
Judah Folkman
Robert J D'Amato
Sandra Ryeom
Harvard University · USBoston Children's Hospital · USUniversity of Oxford · GBUniversity of Pennsylvania · US

Funding

Negative Regulation of VEGF-Mediated AngiogenesisR01CA118374 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RYEOM, SANDRA · 2009 to 2019
$3.4M
Medical Research Council G0601458NCI NIH HHS R01 CA118374
6 · The paper itself

Abstract

Endometriosis is a debilitating disease characterized by the growth of ectopic endometrial tissue. It is widely accepted that angiogenesis plays an integral part in the establishment and growth of endometriotic lesions. Recent data from a variety of angiogenesis-dependent diseases suggest a critical role of bone marrow-derived endothelial progenitor cells (EPCs) in neovascularization. In this study we examined the blood levels of EPCs and mature circulating endothelial cells in a mouse model of surgically induced endometriosis. Fluorescence-activated cell sorting analysis revealed elevated levels of EPCs in the blood of mice with endometriosis compared with control subject that underwent a sham operation. EPC concentrations positively correlated with the amount of endometriotic tissue and peaked 1 to 4 days after induction of disease. In a green fluorescent protein bone marrow transplant experiment we found green fluorescent protein-positive endothelial cells incorporated into endometriotic lesions but not eutopic endometrium, as revealed by flow cytometry and immunohistochemistry. Finally, treatment of endometriosis-bearing mice with the angiogenesis inhibitor Lodamin, an oral nontoxic formulation of TNP-470, significantly decreased EPC levels while suppressing lesion growth. Taken together, our data indicate an important role for bone marrow-derived endothelial cells in the pathogenesis of endometriosis and support the potential clinical use of anti-angiogenic therapy as a novel treatment modality for this disease.

Indexed as

Administration, OralAngiogenesis InhibitorsAnimalsBone Marrow TransplantationCell SeparationCyclohexanesDisease Models, AnimalEndometriosisEndothelial CellsFemaleFlow CytometryGreen Fluorescent ProteinsImmunohistochemistryMiceMice, Inbred C57BLO-(Chloroacetylcarbamoyl)fumagillolAngiogenesis InhibitorsCyclohexanesGreen Fluorescent ProteinsO-(Chloroacetylcarbamoyl)fumagillolSesquiterpenes

Identifiers

PMID21435458
PMCPMC3070089
OpenAlexW2082371998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.